Shenzhen - Delayed Quote CNY
Guangdong Biolight Meditech Co., Ltd. (300246.SZ)
7.48
+0.07
+(0.94%)
At close: May 16 at 3:04:07 PM GMT+8
Key Executives
Amounts are as of -- and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CNY.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. Jinyuan Yan | Chairman & President | -- | -- | 1963 |
| Ms. Jin Liang | VP & Director | -- | -- | 1974 |
| Mr. Wei Liao | VP & Director | -- | -- | 1972 |
| Mr. Yongxing Yang | VP & Secretary of the Board of Directors | -- | -- | 1974 |
| Ms. Wei Xu | Financial Director | -- | -- | 1975 |
| Shuyin Hu | Accounting Supervisor | -- | -- | -- |
Guangdong Biolight Meditech Co., Ltd.
No. 2, Coastal Innovation Road
High-tech Zone
Zhuhai City, 519085
China
- Sector:
- Healthcare
- Industry: Medical Devices
- Full Time Employees:
- 1,335
Description
Guangdong Biolight Meditech Co., Ltd. engages in the research and development, marketing, sale, and service of medical devices, medical consumables, and healthcare solutions. The company offers patient monitors, ECG monitoring equipment, fetal monitors, hemodialysis products, medical products, monitors, and accessories. It operates in Asia, Africa, Europe, North America, and Latin America. The company was founded in 1993 and is headquartered in Zhuhai City, China.
Corporate Governance
Guangdong Biolight Meditech Co., Ltd.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
Upcoming Events Information Not Available
Recent Events
May 25, 2023 at 12:00 AM UTC
Ex-Dividend Date